ArticleOncology letters2017

Downregulation of EGFR in a metastatic brain lesion of EGFR-mutated non-small cell lung cancer using a tyrosine kinase inhibitor: A case report.

Masatoshi Takagaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.